The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...